Cordlife Group Ltd. (CLIFF)

Overview

Cordlife Group Limited is an investment holding company specialized in providing cord blood banking services with international operations spanning Singapore, Hong Kong, India, Malaysia, the Philippines, among others. Founded in 2001 and headquartered in Singapore, the company functions through two main segments: Banking and Diagnostics. Cordlife is dedicated to offering a wide range of healthcare solutions, including the processing and storage of stem cells from umbilical cord blood, cord lining, and cord tissue. Additionally, it extends its services into various diagnostic areas, creating a comprehensive healthcare support system for both mothers and children. Moreover, Cordlife enhances its offerings with the Moms Up mobile app, aimed at providing valuable pregnancy and parenting resources, along with engaging in medical laboratory services, marketing ventures, and property investment activities.

Products and Services

• Cord Blood, Cord Lining, and Cord Tissue Banking Services - These services involve the collection, processing, and long-term storage of stem cells from the umbilical cord blood, lining, and tissue. These stem cells have the potential to be used in future medical treatments for the child or family members.
• Newborn Genetic Screening - A diagnostic service that screens newborns for potential genetic disorders or diseases, aiming to identify any health issues early on.
• Pediatric Vision and Ear Screening - This service offers early detection of vision and hearing issues in children, ensuring timely intervention for optimal development.
• Pediatric Allergen Test - A diagnostic test designed to identify specific allergies in children, enabling parents and healthcare providers to manage or prevent allergic reactions effectively.
• Genetic Talent Test - A novel service analyzing genetic markers that might indicate natural predispositions or talents in children, providing insights for nurturing potential abilities.
• Preimplantation Genetic Screening - This service is offered to prospective parents undergoing IVF, allowing for the genetic screening of embryos before implantation to ensure health and viability.
• Endometrial Receptivity Test - A diagnostic test for women who have experienced unsuccessful IVF attempts, assessing the receptivity of the endometrium to implantation.
• Non-invasive Prenatal Testing - A screening test for pregnant women that analyzes fetal DNA in the mother's blood to detect potential chromosomal abnormalities without risking the pregnancy.
• Newborn Metabolic Screening - A test that screens newborns for rare metabolic disorders that are treatable if detected early, preventing potential developmental issues.
• Moms Up Mobile App - A resourceful mobile application providing pregnancy and parenting guidance for mothers and expectant mothers, aimed at supporting them through the journey of motherhood.
• Medical Laboratory, Marketing, and Property Investment Services - Apart from healthcare, Cordlife engages in ancillary services such as medical laboratory operations, marketing initiatives, and property investments, diversifying its business model and service offerings.